The rating assignment is based on several factors, including Sentara’s leading market position, strong patient demand and history of solid operating margins.
These strengths are offset by Sentara’s growth initiatives, which keep capital spending high.
The outlook is stable, reflecting Moody’s expectations that margins will be sustained and revenue diversification strategies will be absorbed.
More articles on healthcare finance:
Baystate Health asks for $10M to save 200 jobs
Maine hospital to stop outpatient addiction services
Baker Tilly partner appointed to HFMA Principles and Practices Board: 3 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
